Search research articles
Contact Us
Filters
Showing results (51-60 of 427) with videos related to
Page
of 43
Sort By:
Managed Care (Langhorne, Pa.)
|
November 20, 2012
It's in insurers' interest to help cut readmissions
John Carroll
Managed Care (Langhorne, Pa.)
|
August 14, 2013
Hospitals bristle as MedPAC warns of controversial billing initiative
John Carroll
Managed Care (Langhorne, Pa.)
|
April 25, 2013
Consumer-directed health plans continue to gain adherents
John Carroll
Managed Care (Langhorne, Pa.)
|
July 11, 2013
Massachusetts can no longer avoid making tough decisions about costs
John Carroll
Biotechnology Healthcare
|
April 6, 2012
Biogenetic tests emerge from their chrysalis
John Carroll
Biotechnology Healthcare
|
April 6, 2012
Convergence in the midst of competition
John Carroll
Biotechnology Healthcare
|
April 6, 2012
Flexibility in biologic benefit designs can deliver big rewards
John Carroll
Biotechnology Healthcare
|
April 6, 2012
Why Bigger Is Better For Controlling Oncology Spend: It offers less competition - perhaps - but can be a boon for evidence-based pathway initiatives
John Carroll
Biotechnology Healthcare
|
April 6, 2012
The 3.3 percent rx dilemma
John Carroll
Managed Care (Langhorne, Pa.)
|
October 7, 2014
Sovaldi dilemma likely to get worse
John Carroll
Page
of 43
Search research articles
Search
Showing results (51-60 of 427) with videos related to
Sort By:
Page
of 43
Managed Care (Langhorne, Pa.)
|
November 20, 2012
It's in insurers' interest to help cut readmissions
John Carroll
Managed Care (Langhorne, Pa.)
|
August 14, 2013
Hospitals bristle as MedPAC warns of controversial billing initiative
John Carroll
Managed Care (Langhorne, Pa.)
|
April 25, 2013
Consumer-directed health plans continue to gain adherents
John Carroll
Managed Care (Langhorne, Pa.)
|
July 11, 2013
Massachusetts can no longer avoid making tough decisions about costs
John Carroll
Biotechnology Healthcare
|
April 6, 2012
Biogenetic tests emerge from their chrysalis
John Carroll
Biotechnology Healthcare
|
April 6, 2012
Convergence in the midst of competition
John Carroll
Biotechnology Healthcare
|
April 6, 2012
Flexibility in biologic benefit designs can deliver big rewards
John Carroll
Biotechnology Healthcare
|
April 6, 2012
Why Bigger Is Better For Controlling Oncology Spend: It offers less competition - perhaps - but can be a boon for evidence-based pathway initiatives
John Carroll
Biotechnology Healthcare
|
April 6, 2012
The 3.3 percent rx dilemma
John Carroll
Managed Care (Langhorne, Pa.)
|
October 7, 2014
Sovaldi dilemma likely to get worse
John Carroll
Page
of 43